Corporate governance
REFERENCES
1. US Food and Drug Administration (FDA) Breakthrough Device Designation. March 2020.
2. The British Standards Institute (BSI) Breakthrough Device Designation. April 2020.
Contacts for shareholders
You can access current holding and dividend information and update personal information, such as address and direct credit details, via our share registry, InvestorServe.
OncoSil Medical investor relations
Contact OncoSil Medical Investor Relations to ask a question relating to an investment in OncoSil Medical.
WB04-GLO-0720